Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Islets Langerhans”

257 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 257 results

Testing effectiveness (Phase 2)Study completedNCT00602082
What this trial is testing

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Tumor
Cambridge University Hospitals NHS Foundation Trust 84
Not applicableNo Longer AvailableNCT01309022
What this trial is testing

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00001859
What this trial is testing

Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant

Who this might be right for
Diabetes MellitusKidney Failure
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 621
Not applicableUnknownNCT02175459
What this trial is testing

Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy

Who this might be right for
GLUCOSE METABOLISMDIABETESPANCREATIC ISLETS+4 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Testing effectiveness (Phase 2)Study completedNCT02259725
What this trial is testing

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
University of Southern California 3
Not applicableStudy completedNCT00005910
What this trial is testing

Laparoscopy to Remove Pancreatic Tumors (Insulinomas)

Who this might be right for
Insulinoma
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 23
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Not applicableStudy completedNCT03003936
What this trial is testing

Glucose Tolerance, Meal Timing and MTNR1B

Who this might be right for
Non-Diabetic Disorder of Endocrine Pancreas
Universidad de Murcia 280
Large-scale testing (Phase 3)Ended earlyNCT00428597
What this trial is testing

Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Who this might be right for
Carcinoma, Islet CellCarcinoma, Pancreas
Pfizer 171
Not applicableActive Not RecruitingNCT03583528
What this trial is testing

DOTATOC PET/CT for Imaging NET Patients

Who this might be right for
Neuroendocrine TumorsInsulinomaGastrinoma+13 more
British Columbia Cancer Agency 800
Not applicableUnknownNCT03417843
What this trial is testing

Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.

Who this might be right for
Pancreatic CancerPancreatic Neuroendocrine TumorPancreatic Cyst+1 more
HaEmek Medical Center, Israel 20
Testing effectiveness (Phase 2)Study completedNCT00113360
What this trial is testing

RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine CarcinomaIslet Cell Carcinoma
M.D. Anderson Cancer Center 67
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Large-scale testing (Phase 3)UnknownNCT04131582
What this trial is testing

Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes

Who this might be right for
Prediabetic StateInsulin Resistance
Universidad de Guanajuato 34
Testing effectiveness (Phase 2)Temporarily pausedNCT06202066
What this trial is testing

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Who this might be right for
Digestive System Neuroendocrine NeoplasmLung Neuroendocrine NeoplasmMalignant Solid Neoplasm+1 more
Roswell Park Cancer Institute 60
Testing effectiveness (Phase 2)Study completedNCT05997056
What this trial is testing

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Who this might be right for
Neuroendocrine TumorsNETPancreatic Neuroendocrine Tumor+2 more
Aadi Bioscience, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT02230176
What this trial is testing

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II

Who this might be right for
Pancreatic Neuroendocrine Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 84
Not applicableUnknownNCT02121366
What this trial is testing

EUS-guided Ethanol Ablation of an Insulinoma

Who this might be right for
Insulinoma
Guangxi Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06575426
What this trial is testing

Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1HypoglycemiaIslet Cell Transplantation+14 more
Otsuka Pharmaceutical Factory, Inc. 13
Large-scale testing (Phase 3)Looking for participantsNCT05477576
What this trial is testing

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Who this might be right for
GEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor Disease+4 more
RayzeBio, Inc. 338
Next Page